Literature DB >> 17033306

Portal hypertension.

Guadalupe Garcia-Tsao1.   

Abstract

Portal hypertension is the main complication of cirrhosis and is responsible for its most common complications: variceal hemorrhage, ascites, and portosystemic encephalopathy. Portal hypertension is the result of increased intrahepatic resistance and increased portal venous inflow. Vasodilatation (splanchnic and systemic) and the hyperdynamic circulation are hemodynamic abnormalities typical of cirrhosis and portal hypertension. Gastroesophageal varices result almost solely from portal hypertension, although the hyperdynamic circulation contributes to variceal growth and hemorrhage. Ascites results from sinusoidal hypertension and sodium retention, which is in turn secondary to vasodilatation and activation of neurohumoral systems. Hepatic hydrothorax results from the passage of ascites across the diaphragm and into the pleural space. The hepatorenal syndrome represents the result of extreme vasodilatation with an extreme decrease in effective blood volume that leads to maximal activation of vasoconstrictive systems, renal vasoconstriction, and renal failure. Spontaneous bacterial peritonitis is a potentially lethal infection of ascites that occurs in the absence of a local source of infection. Portosystemic encephalopathy is a consequence of both portal hypertension (shunting of blood through portosystemic collaterals) and hepatic insufficiency resulting in the accumulation of neurotoxins in the brain.

Entities:  

Year:  2002        PMID: 17033306     DOI: 10.1097/00001574-200205000-00009

Source DB:  PubMed          Journal:  Curr Opin Gastroenterol        ISSN: 0267-1379            Impact factor:   3.287


  4 in total

1.  Effect of portal hypertension in the small bowel: an endoscopic approach.

Authors:  Pedro Figueiredo; Nuno Almeida; Clotilde Lérias; Sandra Lopes; Hermano Gouveia; Maximino C Leitão; Diniz Freitas
Journal:  Dig Dis Sci       Date:  2007-11-17       Impact factor: 3.199

Review 2.  Peculiar characteristics of portal-hepatic hemodynamics of alcoholic cirrhosis.

Authors:  Massimo Bolognesi; Alberto Verardo; Marco Di Pascoli
Journal:  World J Gastroenterol       Date:  2014-07-07       Impact factor: 5.742

3.  Cross-genotypic polyclonal anti-HCV antibodies from human ascitic fluid.

Authors:  Julio A Gutierrez; Arielle L Klepper; John Garber; Jose L Walewski; Kristin Bateman; Viktoriya Khaitova; Andrew Syder; Donna M Tscherne; Annick Gauthier; Douglas Jefferson; Charles M Rice; Thomas D Schiano; Andrea D Branch
Journal:  J Virol Methods       Date:  2010-10-27       Impact factor: 2.014

4.  Proinflammatory liver and antiinflammatory intestinal mediators involved in portal hypertensive rats.

Authors:  Maria Angeles Aller; Elena Vara; Cruz Garcia; Maria Dolores Palma; Jorge L Arias; Maria Paz Nava; Jaime Arias
Journal:  Mediators Inflamm       Date:  2005-06-09       Impact factor: 4.711

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.